129 related articles for article (PubMed ID: 19666883)
1. Thyroid medication use and subsequent development of dementia of the Alzheimer type.
Harper PC; Roe CM
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):63-9. PubMed ID: 19666883
[TBL] [Abstract][Full Text] [Related]
2. Thyroid disease in patients with dementia of the Alzheimer type.
Small GW; Matsuyama SS; Komanduri R; Kumar V; Jarvik LF
J Am Geriatr Soc; 1985 Aug; 33(8):538-9. PubMed ID: 4019998
[TBL] [Abstract][Full Text] [Related]
3. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
[TBL] [Abstract][Full Text] [Related]
4. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Morris JC; Roe CM; Grant EA; Head D; Storandt M; Goate AM; Fagan AM; Holtzman DM; Mintun MA
Arch Neurol; 2009 Dec; 66(12):1469-75. PubMed ID: 20008650
[TBL] [Abstract][Full Text] [Related]
5. Association of Thyroid Hormone Medication Adherence With Risk of Dementia.
Han S; Jeong S; Choi S; Park SJ; Kim KH; Lee G; Cho Y; Son JS; Park SM
J Clin Endocrinol Metab; 2023 Dec; 109(1):e225-e233. PubMed ID: 37515589
[TBL] [Abstract][Full Text] [Related]
6. Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, Alzheimer's type.
Lobo A; López-Antón R; de-la-Cámara C; Quintanilla MA; Campayo A; Saz P;
Neurotox Res; 2008 Oct; 14(2-3):263-72. PubMed ID: 19073431
[TBL] [Abstract][Full Text] [Related]
7. Mild cognitive impairment represents early-stage Alzheimer disease.
Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
10. Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.
Soliveri P; Zappacosta MB; Austoni L; Caffarra P; Scaglioni A; Testa D; Palazzini E; Caraceni T; Girotti F
Ital J Neurol Sci; 1994 Nov; 15(8):407-11. PubMed ID: 7875958
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.
Snider BJ; Fagan AM; Roe C; Shah AR; Grant EA; Xiong C; Morris JC; Holtzman DM
Arch Neurol; 2009 May; 66(5):638-45. PubMed ID: 19433664
[TBL] [Abstract][Full Text] [Related]
12. The use and misuse of thyroid hormone.
Roti E; Minelli R; Gardini E; Braverman LE
Endocr Rev; 1993 Aug; 14(4):401-23. PubMed ID: 8223339
[No Abstract] [Full Text] [Related]
13. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Wajman JR; Bertolucci PH; Chen ES; Smith MC
Clin Neurol Neurosurg; 2015 Aug; 135():27-33. PubMed ID: 26010393
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
Sato N; Ueki A; Ueno H; Shinjo H; Morita Y
J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270
[TBL] [Abstract][Full Text] [Related]
15. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal examination of American National Adult Reading Test (AMNART) performance in dementia of the Alzheimer type (DAT): validation and correction based on degree of cognitive decline.
Taylor KI; Salmon DP; Rice VA; Bondi MW; Hill LR; Ernesto CR; Butters N
J Clin Exp Neuropsychol; 1996 Dec; 18(6):883-91. PubMed ID: 9157111
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
18. Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type.
Rubin EH; Storandt M; Miller JP; Grant EA; Kinscherf DA; Morris JC; Berg L
Arch Neurol; 1993 Apr; 50(4):380-3. PubMed ID: 8460959
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
[TBL] [Abstract][Full Text] [Related]
20. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.
Devanand DP; Sano M; Tang MX; Taylor S; Gurland BJ; Wilder D; Stern Y; Mayeux R
Arch Gen Psychiatry; 1996 Feb; 53(2):175-82. PubMed ID: 8629893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
